Park Place Capital Corp Raises Position in Chemed Co. (NYSE:CHE)

Park Place Capital Corp raised its position in Chemed Co. (NYSE:CHE - Free Report) by 33.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 2,086 shares of the company's stock after acquiring an additional 522 shares during the period. Park Place Capital Corp's holdings in Chemed were worth $1,105,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CHE. EP Wealth Advisors LLC lifted its position in shares of Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company's stock valued at $814,000 after purchasing an additional 25 shares in the last quarter. Ballentine Partners LLC lifted its position in shares of Chemed by 4.1% during the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company's stock worth $394,000 after buying an additional 26 shares in the last quarter. Creative Planning boosted its stake in shares of Chemed by 2.8% in the 2nd quarter. Creative Planning now owns 1,228 shares of the company's stock worth $667,000 after buying an additional 34 shares during the last quarter. First Heartland Consultants Inc. grew its holdings in shares of Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company's stock valued at $305,000 after acquiring an additional 34 shares in the last quarter. Finally, First Trust Direct Indexing L.P. increased its position in shares of Chemed by 4.5% during the third quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company's stock valued at $533,000 after acquiring an additional 38 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company's stock, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CHE shares. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, November 30th. Royal Bank of Canada decreased their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.

Chemed Price Performance

Shares of CHE traded down $8.34 during trading hours on Thursday, hitting $542.80. The company's stock had a trading volume of 163,327 shares, compared to its average volume of 89,622. The company has a market cap of $8.17 billion, a price-to-earnings ratio of 27.43, a PEG ratio of 2.18 and a beta of 0.47. The business has a 50 day simple moving average of $544.80 and a two-hundred day simple moving average of $563.00. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.32 earnings per share. Research analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date was Monday, November 18th. Chemed's payout ratio is presently 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.